| [1] |
Xu W, Larbi A. Markers of T Cell Senescence in Humans[J]. Int J Mol Sci, 2017, 18(8).pii:E1742.
|
| [2] |
Lopez-Otin C, Blasco MA, Partridge L, et al. The hallmarks of aging[J]. Cell, 2013,153(6):1194-1217.
|
| [3] |
Reed RG. Stress and immunological aging[J]. Curr Opin Behav Sci, 2019, 28:38-43.
|
| [4] |
Salminen A, Kaarniranta K, Kauppinen A. Immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age- related immune deficiency[J]. Cell Mol Life Sci, 2019, 76(10):1901-1918.
|
| [5] |
Fulop T, Dupuis G, Witkowski JM, et al. The role of immunosenescence in the development of age-related diseases[J]. Rev Invest Clin, 2016, 68(2):84-91.
|
| [6] |
Ovadya Y, Landsberger T, Leins H, et al. Impaired immune surveillance accelerates accumulation of senescent cells and aging[J]. Nature communications, 2018, 9(1):5435.
|
| [7] |
Alonso-Arias R, Moro-Garcia MA, Lopez-Vazquez A, et al. NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system[J]. Age (Dordr), 2011, 33(4):591-605.
|
| [8] |
Weyand CM, Yang Z, Goronzy JJ. T-cell aging in rheumatoid arthritis[J]. Curr Opin Rheumatol, 2014, 26(1):93-100.
|
| [9] |
Pawelec G. Age and immunity: What is "Immunosenescence"?[J]. Exp Gerontol, 2018, 105:4-9.
|
| [10] |
Tarazona R, Sanchez-Correa B, Casas-Avilés I, et al. Immunosenescence: limitations of natural killer cell-based cancer immunotherapy[J]. Cancer Immunol Immunother, 2017, 66(2):233-245.
|
| [11] |
Shin MS, Yim K, Moon K, et al. Dissecting alterations in human CD8+ T cells with aging by high-dimensional single cell mass cytometry[J]. Clin Immunol, 2019,200:24-30.
|
| [12] |
Hu B, Li G, Ye Z, et al. Transcription factor networks in aged naive CD4 T cells bias lineage differentiation[J]. Aging Cell, 2019,18(4):e12957.
|
| [13] |
Jadali Z. Th9 cells as a new player in inflammatory skin disorders[J]. Iran J Allergy Asthma Immunol, 2019, 18(2):120-130.
|
| [14] |
Li J, Chen S, Xiao X, et al. IL-9 and Th9 cells in health and diseases- From tolerance to immunopathology[J]. Cytokine Growth Factor Rev, 2017, 37:47-55.
|
| [15] |
Alves AS, Bueno V. Immunosenescence: participation of T lymphocytes and myeloid-derived suppressor cells in aging-related immune response changes[J]. Einstein (Sao Paulo), 2019, 17(2):eRB4733.
|
| [16] |
Voehringer D, Koschella M, Pircher H. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1)[J]. Blood, 2002, 100(10):3698-3702.
|
| [17] |
Larbi A, Fulop T. From "Truly Naïve" to "Exhausted Senescent" T cells: when markers predict functionality[J]. Cytometry A, 2014, 85(1):25-35.
|
| [18] |
Onyema OO, Njemini R, Forti LN, et al. Aging-associated subpopulations of human CD8+ T-lymphocytes identified by their CD28 and CD57 phenotypes[J]. Arch Gerontol Geriatr, 2015, 61(3):494-502.
|
| [19] |
Bi J, Tian Z. NK Cell Exhaustion[J]. Front Immunol, 2017, 8:760.
|
| [20] |
Crooke SN, Ovsyannikova IG, Poland GA, et al. Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses[J]. Exp Gerontol, 2019:110632.
|
| [21] |
Camous X, Pera A, Solana R, et al. NK cells in healthy aging and age- associated diseases[J]. J Biomed Biotechnol, 2012, 2012:195956.
|
| [22] |
Solana R, Alonso MC, Peña J. Natural killer cells in healthy aging[J]. Exp Gerontol, 1999, 34(3):435-443.
|
| [23] |
Salminen A, Kaarniranta K, Kauppinen A. The role of myeloid-derived suppressor cells (MDSC) in the inflammaging process[J]. Ageing Res Rev, 2018,48:1-10.
|
| [24] |
Bjorkstrom NK, Riese P, Heuts F, et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56 dim NK-cell differentiation uncoupled from NK-cell education[J]. Blood, 2010,116(19):3853-3864.
|
| [25] |
Manser AR, Uhrberg M. Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance[J]. Cancer immunol Immunother, 2016, 65(4):417-426.
|
| [26] |
Le Garff-Tavernier M, Beziat V, Decocq J, et al. Human NK cells display major phenotypic and functional changes over the life span[J]. Aging Cell, 2010, 9(4):527-535.
|
| [27] |
Gayoso I, Sanchez-Correa B, Campos C, et al. Immunosenescence of human natural killer cells[J]. J Innate Immun, 2011, 3(4):337-343.
|
| [28] |
Buffa S, Bulati M, Pellicanò M, et al. B cell immunosenescence: different features of naive and memory B cells in elderly[J]. Biogerontology, 2011, 12(5):473-483.
|
| [29] |
Bulati M, Buffa S, Candore G, et al. B cells and immunosenescence: a focus on IgG+IgD-CD27- (DN) B cells in aged humans[J]. Ageing Res Rev, 2011, 10(2):274-284.
|
| [30] |
Qin L, Jing X, Qiu Z, et al. Aging of immune system: Immune signature from peripheral blood lymphocyte subsets in 1068 healthy adults[J]. Aging (Albany NY), 2016,8(5):848-859.
|
| [31] |
Salminen A, Kauppinen A, Kaarniranta K. Myeloid-derived suppressor cells (MDSC): an important partner in cellular/tissue senescence[J]. Biogerontology, 2018, 19(5):325-339.
|
| [32] |
Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system[J]. Nat Rev Immunol, 2009, 9(3):162-174.
|
| [33] |
Howcroft TK, Campisi J, Louis GB, et al. The role of inflammation in age-related disease[J]. Aging, 2013, 5(1):84-93.
|
| [34] |
Scheller J, Chalaris A, Schmidt-Arras D, et al. The pro- and anti-inflammatory properties of the cytokine interleukin-6[J]. Biochim Biophys Acta, 2011, 1813(5):878-888.
|
| [35] |
Moro-Garcia MA, Echeverria A, Galan-Artimez MC, et al. Immunosenescence and inflammation characterize chronic heart failure patients with more advanced disease[J]. Int J Cardiol, 2014, 174(3):590-599.
|
| [36] |
Licastro F, Porcellini E. Persistent infections, immune-senescence and Alzheimer's disease[J]. Oncoscience, 2016, 3(5-6):135-142.
|
| [37] |
Browne TC, McQuillan K, McManus RM, et al. IFN-γ Production by amyloid beta-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease[J]. J Immunol, 2013, 190(5):2241-2251.
|
| [38] |
Martin S, Pérez A, Aldecoa C. Sepsis and immunosenescence in the elderly patient: A review[J]. Front Med (Lausanne), 2017, 4:20.
|
| [39] |
Fenimore J, H AY. Regulation of IFN-gamma expression[J]. Adv Exp Med Biol, 2016,941:1-19.
|
| [40] |
Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function[J]. Nat Immunol, 2004, 5(2):133-139.
|